These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6311128)

  • 21. Pharmacodynamics of antibiotics in experimental bacterial meningitis--two sides to rapid bacterial killing in the cerebrospinal fluid.
    Täuber MG; Sande MA
    Scand J Infect Dis Suppl; 1990; 74():173-8. PubMed ID: 2097706
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Penetration of ceftizoxime (FK 749) into the cerebrospinal fluid (author's transl)].
    Ruf B
    Infection; 1982; 10(2):76-80. PubMed ID: 6284650
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapse of gram-negative bacillary meningitis after cefotaxime therapy.
    Bradsher RW
    JAMA; 1982 Sep; 248(10):1214-5. PubMed ID: 6287048
    [No Abstract]   [Full Text] [Related]  

  • 24. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children.
    Goldwater PN
    Int J Antimicrob Agents; 2005 Nov; 26(5):408-11. PubMed ID: 16216469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children.
    del Rio MA; Chrane D; Shelton S; McCracken GH; Nelson JD
    Lancet; 1983 Jun; 1(8336):1241-4. PubMed ID: 6134039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of cefotaxime and latamoxef for Escherichia coli bacteremia and meningitis in newborn rats.
    Kim KS; Manocchio M; Bayer AS
    Chemotherapy; 1984; 30(4):262-9. PubMed ID: 6086247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefotaxime and desacetylcefotaxime pharmacokinetics in infants and children with meningitis.
    Trang JM; Jacobs RF; Kearns GL; Brown AL; Wells TG; Underwood FL; Kluza RB
    Antimicrob Agents Chemother; 1985 Dec; 28(6):791-5. PubMed ID: 4083862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cerebrospinal fluid penetration after combined administration of cefotaxime and ampicillin to rabbits with staphylococcal meningitis.
    Kobayashi Y; Haruta T; Okura K
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():125-34. PubMed ID: 6094431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cefmenoxime diffusion into cerebrospinal fluid during human purulent meningitis].
    Stahl JP; Croize J; Bru JP; Pegourie B; Blanc-Jouvan F; Bryskier A; Micoud M
    Pathol Biol (Paris); 1985 May; 33(5):365-7. PubMed ID: 3897967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cefotaxime and desacetylcefotaxime in neonates and children: a review of microbiologic, pharmacokinetic, and clinical experience.
    Jacobs RF; Kearns GL
    Diagn Microbiol Infect Dis; 1989; 12(1):93-9. PubMed ID: 2653717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cefotaxim--an alternative in the treatment of purulent meningitis in children?].
    Helwig H; Daschner F
    Dtsch Med Wochenschr; 1982 Sep; 107(36):1343-6. PubMed ID: 6288338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges.
    Nau R; Prange HW; Muth P; Mahr G; Menck S; Kolenda H; Sörgel F
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1518-24. PubMed ID: 8363385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitis.
    Decazes JM; Ernst JD; Sande MA
    Antimicrob Agents Chemother; 1983 Oct; 24(4):463-7. PubMed ID: 6316841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective randomized comparison of cefotaxime vs ampicillin and chloramphenicol for bacterial meningitis in children.
    Jacobs RF; Wells TG; Steele RW; Yamauchi T
    J Pediatr; 1985 Jul; 107(1):129-33. PubMed ID: 3847486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis.
    Scheld WM; Rocha H; Sande MA; Bryan JP
    Am J Med; 1984 Oct; 77(4C):42-9. PubMed ID: 6093518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concentrations of cefotaxime and the desacetyl metabolite in serum and CSF of patients with meningitis.
    Humbert G; Leroy A; Nair SR; Cherubin CE
    J Antimicrob Chemother; 1984 May; 13(5):487-94. PubMed ID: 6330021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cefotaxime treatment of meningitis in children.
    Sow A
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():191-4. PubMed ID: 6094439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gram-negative bacillary meningitis. New therapy and changing concepts.
    Landesman SH; Cherubin CE; Corrado ML
    Arch Intern Med; 1982 May; 142(5):939-40. PubMed ID: 6211153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefotaxime in the cerebrospinal fluid and serum in patients with purulent meningitis.
    Peretti P; Sueri L; Tosi M; Ciammarughi R; Cadeo GP; Milanesi B
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():117-23. PubMed ID: 6094430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective comparison of ceftriaxone and cefotaxime for the short-term treatment of bacterial meningitis in children.
    Scholz H; Hofmann T; Noack R; Edwards DJ; Stoeckel K
    Chemotherapy; 1998; 44(2):142-7. PubMed ID: 9551246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.